Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
06/01/1999 | US5908629 Polysaccharide-protein complex |
06/01/1999 | US5908627 Antigen associated with Type I diabetes mellitus |
06/01/1999 | US5908626 Genetic engineering |
06/01/1999 | US5908623 Compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules |
06/01/1999 | US5908609 Screening methods for compounds useful in the regulation of body weight |
06/01/1999 | CA2251260A1 Escape mutant of the surface antigen of hepatitis b virus |
06/01/1999 | CA2223117A1 Cruciform binding protein |
06/01/1999 | CA2097698C Human dopamine d4 receptor and its uses |
06/01/1999 | CA1340577C Recombinant systems for expressions of cholera b-subunit with the aid of foreign promoters and/or leader peptides |
05/27/1999 | WO1999026069A1 Improvements in or relating to detection of molecules in samples |
05/27/1999 | WO1999025877A1 Reagents and methods useful for detecting diseases of the breast |
05/27/1999 | WO1999025862A2 Chimeric viral packaging signal without gag gene sequences |
05/27/1999 | WO1999025858A1 Alphavirus vectors for paramyxovirus vaccines |
05/27/1999 | WO1999025857A2 Transgenic models of inflammatory disease |
05/27/1999 | WO1999025850A1 Reagents and methods useful for detecting diseases of the breast |
05/27/1999 | WO1999025849A1 Single-chain bifunctional glycoprotein hormones |
05/27/1999 | WO1999025844A1 Mammalian cell death preventing kinase, dpk |
05/27/1999 | WO1999025838A1 Compositions and methods to prevent turkey enteritis |
05/27/1999 | WO1999025837A2 Method for producing virus-like particles on the basis of polyoma viruses |
05/27/1999 | WO1999025836A1 Attaching substances to micro-organisms |
05/27/1999 | WO1999025835A1 Improvements relating to protein accumulation |
05/27/1999 | WO1999025834A1 Dna19355 polypeptide, a tumor necrosis factor homolog |
05/27/1999 | WO1999025833A1 Methods for modulating nerve cell function |
05/27/1999 | WO1999025832A1 Toso |
05/27/1999 | WO1999025831A2 Slit polypeptide and method of modulation of robo with ligands |
05/27/1999 | WO1999025830A1 Transcriptionally regulated g protein-coupled receptor |
05/27/1999 | WO1999025829A2 Cdk2 protein and cdk2 protein complexes |
05/27/1999 | WO1999025828A1 A human 2-19 protein homologue, z219c |
05/27/1999 | WO1999025827A1 Neuralized protein, polynucleotide encoding the same, and antibody recognizing the same |
05/27/1999 | WO1999025826A1 Method and kit for determining severe inflammatory reactions to mosquito bites |
05/27/1999 | WO1999025825A2 EXTENDED cDNAs FOR SECRETED PROTEINS |
05/27/1999 | WO1999025824A1 cDNA SEQUENCE CODING FOR A MUTATED LEPTIN AND APPLICATIONS |
05/27/1999 | WO1999025823A2 Recombinant allergen with reduced enzymatic activity |
05/27/1999 | WO1999025822A1 The exostosin-4 gene |
05/27/1999 | WO1999025820A1 p53CP, A PROTEIN THAT SPECIFICALLY BINDS TO CONSENSUS p53 DNA BINDING SITES |
05/27/1999 | WO1999025818A1 Method of identifying binding site domains that retain the capacity of binding to an epitope |
05/27/1999 | WO1999025810A1 Transgenic animal models for human bladder cancer |
05/27/1999 | WO1999025737A1 Compositions and methods for treatment of autoimmune diseases, using a monoclonal antibody to the interleukin-12 beta2-chain |
05/27/1999 | WO1999025736A1 Chronic lymphocytic leukemia nucleotides and proteins |
05/27/1999 | WO1999025735A1 Chimeric pre-activated transcription factors |
05/27/1999 | WO1999025734A2 Th2 CELL DEPLETION; COMPOSITIONS; METHODS |
05/27/1999 | WO1999025733A2 SUBSTANCES TARGETED TO THE ACTIVE SITE OF THE FtsH PROTEIN, DNA ENCODING SAID SUBSTANCES AND USES THEREOF |
05/27/1999 | WO1999025732A2 Design of coiled-coil dimer derived antagonists of 4-helix bundle cytokine specific receptors |
05/27/1999 | WO1999025731A1 Cyclic peptides and medicinal use thereof |
05/27/1999 | WO1999025730A1 Ikap proteins, nucleic acids and methods |
05/27/1999 | WO1999025728A1 Novel exendin agonist compounds |
05/27/1999 | WO1999025727A2 Novel exendin agonist compounds |
05/27/1999 | WO1999025721A1 Detection and treatment of retinal degenerative disease |
05/27/1999 | WO1999025719A1 Novel physiologically active substance sulphostin, process for producing the same, and use thereof |
05/27/1999 | WO1999025381A1 Linear antigen supporting units |
05/27/1999 | WO1999025377A1 Method for obtaining vaccines for preventing the pathogenic effects related to a retroviral infection |
05/27/1999 | WO1999025376A1 Bacterial vaccines comprising auxotrophic, attenuated strains of listeria expressing heterologous antigens |
05/27/1999 | WO1999025371A1 Novel molecules of the follistatin-related protein family and uses therefor |
05/27/1999 | WO1999014357A3 Reagents and methods useful for detecting diseases of the prostate, breast and ovary |
05/27/1999 | WO1999014330A8 DcR3 POLYPEPTIDE, A TNFR HOMOLOG |
05/27/1999 | WO1999013908A9 Compound inhibiting presenilin 1 for preparing a medicine and a diagnostic agent |
05/27/1999 | WO1999013092A9 Enhancement of mucosal antibody responses by interleukin-6 |
05/27/1999 | WO1999013084A9 Group a streptococcal vaccines |
05/27/1999 | WO1999013075A3 Human genes regulated by human cytomegalovirus and interferon |
05/27/1999 | WO1999012964A3 Kay - a novel immune system protein |
05/27/1999 | WO1999012961A8 Estrogen receptor |
05/27/1999 | WO1999012960A3 P13 ANTIGENS FROM $i(BORRELIA) |
05/27/1999 | WO1999012563A3 Mucosal cytotoxic t lymphocyte responses |
05/27/1999 | WO1999011780A3 Conductine protein and a related agent for diagnosing and treating tumor illnesses |
05/27/1999 | WO1999011660A3 Immunogenic polypeptides that mimic a surface polysaccharide antigen of a pathogenic microorganism, method for obtaining the same, and their use in vaccine compositions |
05/27/1999 | WO1999011655B1 Modular protein libraries and methods of preparation |
05/27/1999 | WO1999010480A3 New tissue-specific calpaines, their production and their use |
05/27/1999 | WO1999006554A3 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN MUSCLE AND OTHER MESODERMAL TISSUES |
05/27/1999 | WO1999006553B1 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN VARIOUS TISSUES |
05/27/1999 | WO1999005270A3 Crustacean antimicrobial peptides, called penaiedines |
05/27/1999 | WO1998055495A3 Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof |
05/27/1999 | WO1998049292A3 Polypeptides associated with activator receptors and their biological applications |
05/27/1999 | CA2320399A1 A human 2-19 protein homologue, z219c |
05/27/1999 | CA2310624A1 Chimeric pre-activated transcription factors |
05/27/1999 | CA2310462A1 Linear antigen supporting units |
05/27/1999 | CA2310228A1 Attaching substances to micro-organisms |
05/27/1999 | CA2310097A1 Novel exendin agonist compounds |
05/27/1999 | CA2309885A1 Recombinant allergen with reduced enzymatic activity |
05/27/1999 | CA2309826A1 Alphavirus vectors for paramyxovirus vaccines |
05/27/1999 | CA2309807A1 Transgenic models of inflammatory disease |
05/27/1999 | CA2309761A1 Th2 cell depletion; compositions; methods |
05/27/1999 | CA2309758A1 Reagents and methods useful for detecting diseases of the breast |
05/27/1999 | CA2309756A1 Reagents and methods useful for detecting diseases of the breast |
05/27/1999 | CA2309390A1 Cdk2 protein and cdk2 protein complexes |
05/27/1999 | CA2309387A1 Method and kit for determining severe inflammatory reactions to mosquito bites |
05/27/1999 | CA2309343A1 Toso |
05/27/1999 | CA2309339A1 Transcriptionally regulated g protein-coupled receptor |
05/27/1999 | CA2309336A1 Neuralized protein, polynucleotide encoding the same, and antibody recognizing the same |
05/27/1999 | CA2308571A1 Single-chain bifunctional glycoprotein hormones |
05/27/1999 | CA2308365A1 Dna19355 polypeptide, a tumor necrosis factor homolog |
05/27/1999 | CA2307539A1 Improvements relating to protein accumulation |
05/27/1999 | CA2306776A1 Methods for modulating nerve cell function |
05/27/1999 | CA2302644A1 Extended cdnas for secreted proteins |
05/26/1999 | EP0918091A1 A gene called XLIS and the XLIS gene product, called doublecortin and their applications |
05/26/1999 | EP0917878A1 Remedies for hepatitis |
05/26/1999 | EP0917592A1 Attenuated respiratory syncytial virus |
05/26/1999 | EP0917586A1 Vector for activating the immune system against cells associated to papilloma viruses or sequences thereof |
05/26/1999 | EP0917585A2 Vectors for delivering viral and oncogenic inhibitors |
05/26/1999 | EP0917584A1 Modified tomato mottle geminivirus coat protein gene |
05/26/1999 | EP0917583A2 Maize promoter sequence for leaf- and stalk-preferred gene expression |